Purple Biotech (PPBT) Prepaid Assets (2016 - 2026)
Purple Biotech's (PPBT) quarterly Prepaid Assets came in at $353000.0 in Q1 2026, down 17.52% year-on-year from $428000.0 in Q1 2025, and up 20.89% on a QoQ basis from $292000.0 in Q4 2025.
Purple Biotech (PPBT) Prepaid Assets (2016 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 11 years of Prepaid Assets data on file, last reported at $353000.0 in Q1 2026.
- On a quarterly basis, Prepaid Assets fell 17.52% year-over-year to $353000.0 in Q1 2026; TTM through Mar 2026 was $353000.0, a 17.52% decrease from a year earlier, with the FY2025 full-year figure at $292000.0, down 23.96% from the prior year.
- Prepaid Assets for Q1 2026 stood at $353000.0, up from $292000.0 in the prior quarter.
- Over the last five years, Prepaid Assets for PPBT reached as high as $2.4 million in Q1 2022 and fell as low as $292000.0 in Q4 2025.
- Historically, Prepaid Assets has averaged $780235.3 across 5 years, with a median of $548000.0 in 2024.
- Across the five-year window, Prepaid Assets jumped 57.96% in 2022 and sank 67.1% in 2023, its largest moves.
- Year by year, Prepaid Assets stood at $1.1 million in 2022, then sank by 67.1% to $376000.0 in 2023, then increased by 2.13% to $384000.0 in 2024, then decreased by 23.96% to $292000.0 in 2025, then climbed by 20.89% to $353000.0 in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $353000.0 in Q1 2026, $292000.0 in Q4 2025, and $320000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 353,000.00 |
| Dec 31, 2025 | 292,000.00 |
| Sep 30, 2025 | 320,000.00 |
| Jun 30, 2025 | 394,000.00 |
| Mar 31, 2025 | 428,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Sep 30, 2024 | 638,000.00 |
| Jun 30, 2024 | 473,000.00 |
| Mar 31, 2024 | 548,000.00 |
| Dec 31, 2023 | 376,000.00 |
| Sep 30, 2023 | 634,000.00 |
| Jun 30, 2023 | 984,000.00 |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 1.43 Mn |
| Mar 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | 1.27 Mn |
| Sep 30, 2021 | 1.13 Mn |
| Jun 30, 2021 | 1.12 Mn |